Eurofins BioPharma Product Testing Italy opens a new dedicated virucidal testing laboratory in its Milan campus
Eurofins BioPharma Product Testing Italy opens a new dedicated virucidal testing laboratory in its Milan campus
Disinfectant products have become pervasive in our daily lives as a result of COVID-19, being used much more widely and frequently than before and demand for and development of such products has increased significantly, as have testing requirements.
The additional 400sqm BioSafety Level 2 laboratory is fully dedicated to carrying out virucidal testing and studies on disinfectant products in response to the increasing global demand for such services in the wake of the COVID-19 pandemic.
This state-of-the-art ISO 17025 accredited facility, certified for Good Laboratory Practices (GLP) and Good Manufacturing Practice, accredited by the Italian drug agency AIFA and audited by the North American Food and Drug Administration (FDA), is ready to provide testing services and studies to assess and demonstrate the general virucidal activity (against enveloped and/or non-enveloped viruses) of products and determine efficacy levels against specific viruses, like coronaviruses or influenza ones. Tests are performed following international validated standards and guidance; CEN, ISO, ASTM and OECD. With 8 biohazard virucidal workstations and cell culture manipulation testing equipment, the Italian laboratory will increase Eurofins Biopharma Product Testing’s (hereinafter, BPT) virucidal study capacity from 40 to 100 studies per month.
Eurofins BPT Italy, based in a 18,000 sqm campus in Milan, employees 350 people and provides laboratory testing services and research services to the disinfectant, medical device and the pharmaceutical industries. Our experts have over 20 years’ experience in assessing the efficacy of disinfectant products against microorganisms and viruses in its microbiological laboratories.
The new virucidal testing laboratory contributes to expanding Eurofins footprint in the fight against the coronavirus as well as supporting development, regulatory and testing activities to clients serving the healthcare, medical and pharmaceutical sector worldwide.
More information on this, and other COVID-19 related services offer is available on https://www.eurofins.com/covid-19-product-testing/